Follicle Depletion Provides a Permissive Environment for Ovarian Carcinogenesis

Lab / animal OA: closed
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-08-04 ⓘ

Germ cell-deficient mice with oncogenic mutations developed ovarian tubular adenomas after follicle depletion, demonstrating that this depletion creates a permissive environment for epithelial cell oncogenic transformation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

We modeled the etiology of postmenopausal biology on ovarian cancer risk using germ cell-deficient white-spotting variant (Wv) mice, incorporating oncogenic mutations. Ovarian cancer incidence is highest in peri- and postmenopausal women, and epidemiological studies have established the impact of reproductive factors on ovarian cancer risk. Menopause as a result of ovarian follicle depletion is thought to contribute to higher cancer risk. As a consequence of follicle depletion, female Wv mice develop ovarian tubular adenomas, a benign epithelial tumor corresponding to surface epithelial invaginations and papillomatosis frequently found in postmenopausal human ovaries. Lineage tracing using MISR2-Cre indicated that the tubular adenomas that developed in Wv mice were largely derived from the MISR2 lineage, which marked only a fraction of ovarian surface and oviduct epithelial cells in wild-type tissues. Deletion of p27, either heterozygous or homozygous, was able to convert the benign tubular adenomas into more proliferative tumors. Restricted deletion of p53 in Wv/Wv mice by either intrabursal injection of adenoviral Cre or inclusion of the MISR2-Cre transgene also resulted in augmented tumor growth. This finding suggests that follicle depletion provides a permissive ovarian environment for oncogenic transformation of epithelial cells, presenting a mechanism for the increased ovarian cancer risk in postmenopausal women.

My notes (saved in your browser only)

MeSH descriptors

Cell Transformation, Neoplastic Cyclin-Dependent Kinase Inhibitor p27 Ovarian Follicle Ovarian Neoplasms Tumor Suppressor Protein p53 Animals Cell Transformation, Neoplastic Cyclin-Dependent Kinase Inhibitor p27 Female Humans Mice Mutation Neoplasms, Experimental Ovarian Follicle Ovarian Neoplasms Ovarian Neoplasms Ovarian Neoplasms Postmenopause Tumor Suppressor Protein p53

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-11-15T09:34:25.365398+00:00
pubmed
last seen: 2026-10-08T21:18:11.460223+00:00
unpaywall
last seen: 2026-11-22T06:57:01.821430+00:00